Pipeline Watch: Respiratory Syncytial Virus Vaccine approved in the US As ASCO Dominates Clinical Trial Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.